The World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) published Cancer Prevention Recommendations in 2018 focused on modifiable lifestyle factors. To examine how adherence to WCRF/AICR Recommendations via the 2018 WCRF/AICR Score was associated with risk for all-cause, cancer, and CVD mortality outcomes among older US adults. Baseline and follow-up questionnaire data (N = 177,410) were used to calculate weight, physical activity, and diet components of the 2018 WCRF/AICR Score (0–7 total points). Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated, stratified by sex and smoking status. There were 16,055 deaths during a mean 14.2 person-years. Each one-point Score increase was associated with a 9–26% reduced mortality risk for all outcomes, except for current male smokers’ cancer mortality risk. When the Score was categorized comparing highest (5–7 points) vs. lowest (0–2 points) Scores, associations with reduced all-cause mortality risk were strongest in former smokers (HRmales: 0.51, 95%CI: 0.43–0.61; HRfemales: 0.38, 95%CI: 0.31–0.46), followed by current smokers (HRmales: 0.55, 95%CI: 0.34–0.89; HRfemales: 0.44, 95%CI: 0.32–0.59) and never smokers (HRmales: 0.57, 95%CI: 0.47–0.70; HRfemales: 0.50, 95%CI: 0.41–0.60). An association with cancer mortality risk was also seen in former smokers (HRmales: 0.59, 95%CI: 0.43–0.81; HRfemales: 0.52, 95%CI: 0.37–0.73) and female current (HRfemales: 0.55, 95%CI:0.32–0.96) and never smokers (HRfemales: 0.57, 95%CI: 0.40–0.80); findings were not statistically significant in other strata. For CVD mortality, highest vs. lowest Scores were associated with a 49–73% risk reduction, except in male never and current smokers. In exploratory analysis, physical activity, body weight, alcohol, and plant-based foods were found to be predominant components in the Score. Greater 2018 WCRF/AICR Scores were associated with lower mortality risk among older adults. Future research can explore how smoking modifies these relationships, and further examine different populations and other cancer-relevant outcomes.